ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Nephrology

Top Nephrology Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RADCLIFFE M THOMAS MD PA

Nephrology

181

$58.4K

14
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

82%
prescriptions for brand name drugs

Avg: 31%

$323
Average prescription price

Avg: $135

MELANIE HAROUN M.D.

Nephrology

322

$87.1K

22
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 31%

$270
Average prescription price

Avg: $135

MATTHEW WEIR M.D.

Nephrology

397

$44.4K

47
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 31%

$112
Average prescription price

Avg: $135

VEENA ACHARYA MD

Nephrology

450

$16.2K

95
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 31%

$36
Average prescription price

Avg: $135

JASWINDER SIDHU M.D.

Nephrology

474

$125K

64
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 31%

$264
Average prescription price

Avg: $135

CIARAN BROWNE MD

Nephrology

482

$31.2K

71
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 31%

$65
Average prescription price

Avg: $135

MICHAEL CHOI M.D.

Nephrology

488

$92.9K

44
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 31%

$190
Average prescription price

Avg: $135

PAUL TURER M.D.

Nephrology

505

$46.2K

76
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 31%

$92
Average prescription price

Avg: $135

HUI CAI M.D.

Nephrology

509

$24.9K

51
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 31%

$49
Average prescription price

Avg: $135

KULWANT MODI MD,FACP,FASN

Nephrology

547

$61.1K

54
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$112
Average prescription price

Avg: $135

ADNAN HASHMI MD

Nephrology

608

$73.7K

96
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 31%

$121
Average prescription price

Avg: $135

ROBERT FULD M.D.

Nephrology

633

$79.1K

87
62 are 65+

14%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 31%

$125
Average prescription price

Avg: $135

ALI GHORBANI M.D.

Nephrology

633

$133K

106
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 31%

$211
Average prescription price

Avg: $135

HELEN CHANG-DEGUZMAN M.D.

Nephrology

661

$73K

102
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 31%

$110
Average prescription price

Avg: $135

TIN MAUNG M.D.

Nephrology

683

$108K

99
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 31%

$159
Average prescription price

Avg: $135

NIRMALA YADLA MD

Nephrology

696

$159K

75
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 31%

$229
Average prescription price

Avg: $135

UTPAL DUTTA MD

Nephrology

698

$75.9K

94
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 31%

$109
Average prescription price

Avg: $135

TAREK SALKINI M.D.

Nephrology

700

$117K

57
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 31%

$167
Average prescription price

Avg: $135

LEONID KLOPOUH M.D.

Nephrology

709

$71.1K

74
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 31%

$100
Average prescription price

Avg: $135

MOKHTAR NASIR MD

Nephrology

752

$126K

92
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 31%

$167
Average prescription price

Avg: $135

AJAY KUMAR M.D.

Nephrology

768

$189K

140
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 31%

$246
Average prescription price

Avg: $135

IRA MANDELL M.D.

Nephrology

801

$231K

116
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 31%

$288
Average prescription price

Avg: $135

RAVINDER SINDHWANI MD

Nephrology

811

$125K

91
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 31%

$154
Average prescription price

Avg: $135

GAIL SEIKEN M.D.

Nephrology

813

$175K

77
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 31%

$215
Average prescription price

Avg: $135

FRANK KRIGER M.D.

Nephrology

817

$101K

72
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 31%

$123
Average prescription price

Avg: $135

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank